<DOC>
	<DOCNO>NCT00187070</DOCNO>
	<brief_summary>The main purpose study find feasible deliver multi-agent chemotherapy regimen feature short , intensive , immunophenotype-directed approach , include intensification phase hematopoietic stem cell support child large cell lymphoma</brief_summary>
	<brief_title>Large Cell Lymphoma Pilot Study III</brief_title>
	<detailed_description>Secondary objective include document toxicity associate treatment regimen , estimate response rate survival participant large cell lymphoma treat protocol . Patients treated induction , consolidation , maintenance treatment . Induction MIED chemotherapy - High dose methotrexate , ifosfamide , etoposide , dexamethasone 2 cycle . High-dose methotrexate 8 gm/m2 Day 1 leucovorin rescue Ifosfamide 2 gm/m2/day day 2-4 ( total 3 day ) Etoposide ( VP-16 ) 200 mg/m2/day Days 2-4 ( total 3 day ) Dexamethasone 40 mg/m2/day IV day 1-4 ( give IV PO daily x 4 ) Intrathecal MHA , age adjust dosage . Consolidation COPADM chemotherapy 2 cycle - cyclophosphamide , vincristine , prednisone , adriamycin , high-dose methotrexate COPAM # 1 High dose methotrexate ( HD MTX ) 5 gm/m2 IV 4 hour Day 1 leucovorin rescue ; Doxorubicin 60 mg/m2 IV 6 hour Day 2 , Vincristine 2.0 mg/m2 ( 2.0 mg max ) Day 1 , Cyclophosphamide 500 mg/m2/day ( divide every 12 hour ) Days 2-4 , Prednisone 60 mg/m2 ( divide bid ) Days 1-5 , Intrathecal MHA , age adjust dosage . COPADM # 2 - like COPADM # 1 except : 1. cyclophosphamide dose increase 1 gm/m2/day divide every 12 hour Days 2-4 , 2. second dose vincristine give Day 6 . DAC chemotherapy x 1 cycle - Dexamethasone , cytarabine , carboplatin Carboplatin ( AUC 8 ) Day 1 ; Ara-C 2 gm/m2/dose q12 x 2 Day 2 Dexamethasone 40 mg/m2/day Days 1-4 ; ITMHA dose age adjust . Hematopoietic Stem Cell Transplantation - high-dose cyclophosphamide etoposide Involved field radiation primary tumor give 3-4 week . Participants CNS disease diagnosis also receive cranial irradiation . Maintenance chemotherapy Vinblastine 6 mg/m2 IV weekly one year</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Patient must previously untreated , except steroid emergency radiation therapy . Patient must less equal 18 year age . Patient must histologic diagnosis large cell NonHodgkin lymphoma . The immunophenotype tumor cell must either Tcell nonBcell , nonTcell . Participants Bcell immunophenotype NHL .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>